salt semaglutide GLP-1 for Medical Weight Loss in Wappingers Falls Semaglutide | C187H291N45O59 | CID

The obesity drug market is currently valued at $2.82 billion and could reach $54 billion by 2030 with the advent of drugs like GLP-1 agonists that have clinically proven weight loss effects

While everyones journey is different, many of our clients begin to see results within a few weeks

Final Takeaways: How to Think Critically About Peptides The conversation surrounding peptides must evolve beyond treating them as a single, uniform category

Evidence also shows that when people stop taking GLP-1s, weight regain is common, raising the risk of worsening health over time

2 Participants received 2.4 mg of semaglutide once weekly or a placebo, alongside lifestyle interventions